October 18, 2024  l  Sign Me Up

Illustration by kentoh/stοck.adοbe.com

The cannabis industry is undergoing significant transformation, driven largely by the rise of multistate operators.

Plenty of independent marijuana business owners and legacy OGs are already struggling with things such as out-of-touch regulators, price gouging, compliance demands and product recalls.

The fear that MSOs might overtake their home markets only adds to the difficulties cannabis OGs face.

These operators worry they'll be pushed aside by corporate interests with more influence, power and money.

But by really understanding the role of MSOs, cannabis legacy operators can rest easier.

The relationships between cannabis OGs and MSOs don't have to be adversarial.

At the end of the day, the aligned motivations and shared goals of a healthier and more accessible cannabis industry can drive progress and consumer advocacy. Read story >

More Headlines

• California cannabis lab official fired for violations, not whistleblowing, state says. Read story >
• New Delaware law protects banks that work with state's marijuana businesses. Read story >

Help inform the cannabis industry!

Cannabis business leaders, please take our anonymous survey to help gather important data to inform MJBizDaily reporting and resources.

Big-picture view of global cannabis markets

E U R O P E

Germany's MMJ sales to exceed $455 in 2024

Photo by RomanR/stock.adobe.com

Medical cannabis sales in Germany are on pace to exceed a record 420 million euros (roughly $455.2 million) in 2024 and could reach 1 billion euros by 2028.

That's according to "The German Cannabis Report" from Prohibition Partners, a London-based data and market intelligence company.

Sales of medical cannabis in state-licensed pharmacies in the European nation increased 30% in the third quarter of 2023 and accelerated more after new laws took effect in April, the report notes.

Germany, which legalized medical cannabis in 2017, has 200,000-plus patients in a nation of more than 84 million residents. Read story >

C A N A D A

Cannabis sales in Ontario rise 21% in first half of year

Photo by rabbit75_fot/stock.adobe.com

Cannabis sales in Ontario, Canada, surged during the first half of the year, with licensed retailers selling 21% more marijuana by volume than they did during the same period last year.

According to a report from the Ontario Cannabis Store (OCS), the government-owned marijuana wholesaler shipped 50.2 million units of regulated products to retailers in the province between Jan. 1 and June 30, up 44 million compared to the same period in 2023.

Sales at authorized cannabis stores in the province reached more than $1 billion during the first six months of 2024, according to the OCS report, "Ontario Cannabis Marketplace: By the Numbers."

Chris Jones, president of Toronto-headquartered retailer Cannabis Xpress, said that OCS sales are likely up because more stores were open during the first half of 2024 compared to the same period last year.

"Per-store sales probably aren't increasing," Jones told MJBizDaily. "On a per-store basis, sales probably went down just because there are more stores in certain areas." Read story >

R E T A I L

Wyld dominates edibles category in adult-use marijuana markets

Graphic by MJBizDaily/Emerald

Wyld is well on its way to becoming the top-selling cannabis edibles brand in every U.S. state, a goal the Oregon-based company has set as states continue to launch regulated adult-use marijuana markets.

Of the 13 adult-use markets analyzed by MJBizDaily, Wyld was the top-selling brand in more than half.

"We don't plan on slowing down any time soon," Rachael Smith, Wyld's marketing production manager, told MJBizDaily.

Wyld leads the edibles category in sales so far this year in six Western states, including Arizona, California, Colorado, Nevada, Oregon and Washington, as well as Michigan, where sales rival California based on several metrics.

The only other brand to lead multiple states in the analysis was Green Thumb Industries' Incredibles brand. Read story >

E U R O P E

Poland medical cannabis import limits set to double in 2024

Photo by Telly/stock.adobe.com

Poland is set to significantly increase the import cap on medical cannabis based on continually expanding demand in what is fast becoming one of Europe's most exciting markets.

According to new documents seen by Business of Cannabis, Poland's chief pharmaceutical inspectorate - which is tasked with "supervising the manufacture and marketing of medicinal products" - says the estimated annual demand for medical cannabis in Poland has almost doubled. Read story >

More Headlines

• Vice President Harris pledges Black jobs in federal marijuana legalization. Read story >
• California cannabis lounges and retailers outline plans to embrace cafe law. Read story >
• Native American tribes bridge gap in Minnesota marijuana market. Read story >

Sponsored

A G E N D A

MJBizCon Conference Agenda Now LIVE!

It's time to celebrate the launch of the most comprehensive MJBizCon to date — we're talking 200+ speakers and four full days of sessions.

This year we're doubling down on our International Regulatory Roundups conference track. Below are a few session highlights. (Check back each week for more.)

INTERNATIONAL REGULATORY ROUNDUP

Crafting an Authentic Brand in the Cannabis Industry

Friday, Dec. 6 • 10:50-11:30 a.m.

Stefan Fritsch

Founder, Grünhorn

Stefan Fritsch is the Founder and Chairman of Grunhorn, Germany's largest cannabis online pharmacy, accounting for one fifth of filled scripts in that market. As a cannabis pharmacy, Grunhonr offers doctors and patients the largest possible selection of medical cannabis flowers from various manufacturers in order to ensure appropriate therapy and treatment.

Chief Executive Officer, CANNAVIGIA

Timo spent more than 15 years helping businesses to innovate business models and starting new ventures. His passion for accelerating business transformation—combined with a childhood affinity for cultivation—ultimately led him to the horticulture and cannabis industry. Today, he serves as CEO at CANNAVIGIA supporting cannabis cultivators and other players along the supply chain with software and consulting services.

Dr. Constantin von der Groeben

Co-founder & Managing Director - DEMECAN

Dr. Constantin von der Groeben is a lawyer and one of the co-founders and Managing Director of DEMECAN, the only independent German producer of medical cannabis operating under the mandate of the Federal Institute for Drugs and Medical Devices (BfArM). Dr. von der Groeben is well-connected within the German and European cannabis industries and maintains close contacts with political decision-makers. He aims to provide patients in Germany with access to medical cannabis of the highest pharmaceutical quality, "Made in Germany." 

R E S O U R C E S

• MJBizMagazine Sept/Oct issue: High Stakes Election
• Fuel Your Fire at MJBizCon, Dec. 3-6 – Register now
• Gain new leads + land big deals at MJBizCon – Book a booth
• Make informed decisions with MJBiz Factbook – Get data
• MJBiz Free Cannabis 101 Course – Sign up and start learning
• MJBizDaily Reports and Buyers Guides – Download
• MJBiz Media Kit – Advertise with us

MJBizDaily is the leading resource for the cannabis industry, cited by The Wall Street Journal, Forbes and Harvard Business Review. MJBiz also produces the No. 1 cannabis business conference, MJBizCon.

Share MJBizDaily

Forward this email to friends and colleagues to keep them on the up and up with the latest cannabis business news and insights from MJBiz.

MJBizCon 2024

Dec. 3-6, 2024  l  Las Vegas  |  Register Now